BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34726381)

  • 1. Supramolecular Drug Delivery System from Macrocycle-Based Self-Assembled Amphiphiles for Effective Tumor Therapy.
    Chen J; Zhang Y; Zhao L; Zhang Y; Chen L; Ma M; Du X; Meng Z; Li C; Meng Q
    ACS Appl Mater Interfaces; 2021 Nov; 13(45):53564-53573. PubMed ID: 34726381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoresponsive transformation from spherical to nanotubular assemblies: anticancer drug delivery using macrocyclic cationic gemini amphiphiles.
    Dey S; Chatterjee S; Patel A; Pradhan N; Srivastava D; Patra N; Bhattacharyya A; Manna D
    Chem Commun (Camb); 2021 May; 57(38):4646-4649. PubMed ID: 33881081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of supramolecular star-shaped amphiphilic copolymers for ROS-triggered drug release.
    Zuo C; Peng J; Cong Y; Dai X; Zhang X; Zhao S; Zhang X; Ma L; Wang B; Wei H
    J Colloid Interface Sci; 2018 Mar; 514():122-131. PubMed ID: 29248814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-sensitive small molecule nanodrug self-assembled from amphiphilic vitamin B6-E analogue conjugate for targeted synergistic cancer therapy.
    Yan G; Chen R; Xiong N; Song J; Wang X; Tang R
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111000. PubMed ID: 32247946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular design of peptide amphiphiles for controlled self-assembly and drug release.
    Liu Z; Tang X; Feng F; Xu J; Wu C; Dai G; Yue W; Zhong W; Xu K
    J Mater Chem B; 2021 Apr; 9(15):3326-3334. PubMed ID: 33881438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.
    Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L
    Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles.
    Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM
    J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
    Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H
    Liang YX; Sun XY; Xu DZ; Huang JR; Tang Q; Lu ZL; Liu R
    Bioorg Chem; 2022 Feb; 119():105559. PubMed ID: 34952244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-responsive polymersomes with a charge-switch for targeted drug delivery.
    Zhou Y; Chen R; Yang H; Bao C; Fan J; Wang C; Lin Q; Zhu L
    J Mater Chem B; 2020 Jan; 8(4):727-735. PubMed ID: 31894822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica nanobeans dual-functionalized with AIEgens and leaning pillar[6]arene-based supramolecular switches for imaging and stimuli-responsive drug release.
    Li X; Han J; Qin J; Sun M; Wu J; Lei L; Li J; Fang L; Yang YW
    Chem Commun (Camb); 2019 Dec; 55(94):14099-14102. PubMed ID: 31641718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous vitamin C triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency.
    Zhu Y; He Y; Su T; Li C; Cai S; Wu Z; Huang D; Zhang X; Cao J; He B
    J Mater Chem B; 2020 Jun; 8(23):5109-5116. PubMed ID: 32412025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient co-delivery of microRNA 21 inhibitor and doxorubicin to cancer cells using core-shell tecto dendrimers formed via supramolecular host-guest assembly.
    Song C; Xiao Y; Ouyang Z; Shen M; Shi X
    J Mater Chem B; 2020 Apr; 8(14):2768-2774. PubMed ID: 32154812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-responsive supramolecular vesicles based on water-soluble pillar[6]arene and ferrocene derivative for drug delivery.
    Duan Q; Cao Y; Li Y; Hu X; Xiao T; Lin C; Pan Y; Wang L
    J Am Chem Soc; 2013 Jul; 135(28):10542-9. PubMed ID: 23795864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilayer Nanocarriers with Protein-Acid Conjugation for Prolonged Release and Enhanced Anticancer Effects.
    Hou H; Zhang D; Zeng J; Zhou L; Wang Z; Yao M; Ren J; Hu N; Wang Y
    Langmuir; 2019 Mar; 35(10):3710-3716. PubMed ID: 30727729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multistimuli-responsive supramolecular vesicles based on water-soluble pillar[6]arene and SAINT complexation for controllable drug release.
    Cao Y; Hu XY; Li Y; Zou X; Xiong S; Lin C; Shen YZ; Wang L
    J Am Chem Soc; 2014 Jul; 136(30):10762-9. PubMed ID: 25033305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin.
    Ostos FJ; Lebrón JA; Moyá ML; López-López M; Sánchez A; Clavero A; García-Calderón CB; Rosado IV; López-Cornejo P
    Chem Asian J; 2017 Mar; 12(6):679-689. PubMed ID: 28112869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.